Latest News - Roche

Tuesday, January 16, 2018 | Patents, Roche

Roche CEO Says Upcoming Patent Losses Putting Pressure on Profitability

Roche chief executive Severin Schwan acknowledged that some of the company's "highly profitable medicines [are] coming off patent," and while it has new medicines "to ramp up&hellip…

Read the full story

Friday, July 08, 2016 | Clinical Trials, Eleven Biotherapeutics, Roche

Eleven Biotherapeutics Announces Effectiveness of Investigational New Drug Application for EBI-031

Eleven Biotherapeutics announced that the company’s investigational new drug application for EBI-031, a humanized monoclonal antibody that potently binds interleukin-6 (IL-6) and inhibits all kn…

Read the full story

Monday, June 13, 2016 | Acquisitions/Mergers, Eleven Biotherapeutics, Roche

Eleven Biotherapeutics Announces Signing of Exclusive License Agreement with Roche

Eleven Biotherapeutics announced that it has entered into an exclusive license agreement with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. (Roche) relating to Eleven’s Interleukin-6 (IL-…

Read the full story

Wednesday, November 18, 2015 | Earnings & Financials, Retina, Genentech, Ophthotech, Roche

Genentech Elects to Exercise Its Right to Opt-in to the Novartis Portion of the Ophthotech/Novartis Ex-US Agreement for Fovista to Treat Wet AMD

Ophthotech announced that Genentech has elected to exercise its option to participate in the financial arrangements relating to Novartis’ rights under the Ophthotech/Novartis ex-US agreement for…

Read the full story